Click here to access press releases from Astellas Pharma Inc. located in Tokyo, Japan.
May 16, 2017
May 10, 2017Astellas Announces Decision to Discontinue ASP8273 Treatment Arm and Close Randomization for Clinical Study Protocol 8273-CL-0302- Decision follows recommendation of Independent Data Monitoring Committee -
- Apr 27, 2017Astellas Americas President Jim Robinson to discuss the importance of listening to patients in tackling health decision-making, financial burden and transparency in care
Apr 26, 2017
- Apr 10, 2017Long recognized for her impact in marketing and communications throughout the biopharma industry.